Talkspace Is Maintained at Equal-Weight by Barclays
Talkspace Analyst Ratings
TD Cowen Maintains Talkspace(TALK.US) With Buy Rating, Maintains Target Price $5
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Raises Target Price to $3
Needham Maintains Talkspace(TALK.US) With Hold Rating
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Maintains Target Price $2
Talkspace (TALK) Gets a Hold From Barclays
Barclays Maintains Talkspace(TALK.US) With Hold Rating, Cuts Target Price to $2
TD Cowen Maintains Talkspace(TALK.US) With Buy Rating, Maintains Target Price $5
Talkspace Analyst Ratings
Needham Maintains Talkspace(TALK.US) With Hold Rating
Needham Sticks to Its Hold Rating for Talkspace (TALK)
Talkspace Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Talkspace (TALK), Vir Biotechnology (VIR) and Alvotech (ALVO)
TD Cowen Remains a Buy on Talkspace (TALK)
Talkspace (TALK) Receives a Hold From Barclays
Talkspace Analyst Ratings
Barclays Issues a Hold Rating on Talkspace (TALK)
Buy Rating Affirmed for Talkspace Amid Strong Financial Performance and Strategic Market Positioning
Barclays Initiates Coverage On Talkspace With Equal-Weight Rating, Announces Price Target of $2.5